Joseph R. Shaw: Honoured to Be Recognised as a Top Peer Reviewer for JTH at ISTH 2026
Joseph R. Shaw, Director of Research Plus Program at Ottawa Department of Medicine, EHJ-CVP Associate Editor at European Heart Journal, shared on LinkedIn:
”Peer review may not be the most visible—or glamorous—part of science.
It often happens quietly, outside normal working hours, and with little recognition.
But it is essential to maintaining the quality, rigour, and credibility of the scientific literature.
I’m honoured to be recognised as one of the Journal of Thrombosis and Haemostasis (JTH) Top Peer Reviewers.
I’m proud to support a leading journal in thrombosis and haemostasis and to contribute to the careful evaluation and strengthening of research in our field.
Peer review is both a responsibility and a privilege, and this recognition means a great deal to me.
Thank you to the JTH editorial team for the recognition, and to the authors whose work I have had the opportunity to review.
Strong science depends on the collective efforts of researchers, editors, and reviewers.”
Stay updated with Hemostasis Today.
-
Jul 15, 2026, 14:27Factor XIII and the Future of Anticoagulation in VTE
-
Jul 15, 2026, 14:26Matthew D. Neal: From Platelet Biology to Patient Impact at ISTH 2026
-
Jul 15, 2026, 14:15Sarah Richardson: Today, I Ask You to Stand with the Bleeding Disorders Community
-
Jul 15, 2026, 14:03Anna Randi: Imperial College London’s Vascular Haemostasis and Thrombosis Team Shines at ISTH 2026
-
Jul 15, 2026, 13:53Akhil Antony Konkoth: Galectin-9 Emerges as a Key Mediator of Venous Thromboinflammation
-
Jul 15, 2026, 13:48Sabine Eichinger: New Insights into Recurrence Risk After Provoked VTE at ISTH 2026
-
Jul 15, 2026, 13:44Shirley D’Sa: Vitamin B6 Offers a New Clue in the POEMS Syndrome Puzzle
-
Jul 15, 2026, 13:43Katarina Miljević: New Insights into Recombinant tPA and FXI Inhibition at ISTH 2026
-
Jul 15, 2026, 13:31Sandrine Meunier: ISTH 2026 Highlights Consensus on Pediatric Hemostatic Assessment